MktsMarkets

Bionano Genomics, Inc.
NASDAQ: BNGOKey statistics
BNGO News
Stories mentioning BNGO from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 6,687 | 7,951 | 7,367 | 6,733 | 6,457 | 8,163 | 6,073 | 7,771 |
| Cost of Goods Sold | 3,435 | 4,551 | 3,997 | 3,256 | 3,519 | 4,746 | 14,519 | 5,186 |
| Gross Profit | 3,252 | 3,400 | 3,370 | 3,477 | 2,938 | 3,417 | (8,446) | 2,585 |
| Operating Expenses | ||||||||
| Research & Development | 3,139 | 3,229 | 2,844 | 2,931 | 2,370 | 3,476 | 4,717 | 6,831 |
| Sales General & Admin | 8,010 | 8,707 | 9,064 | 8,346 | 9,033 | 11,746 | 9,464 | 11,557 |
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | (7,897) | (8,536) | (8,538) | (7,800) | (8,465) | (11,941) | (43,901) | (17,018) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | (619.00) | 363.00 | (219.00) | 676.00 | 5,080 | (8,407) | (697.00) | 363.00 |
| Pretax Income | (8,293) | (7,897) | (8,489) | (6,847) | (3,095) | (20,124) | (44,222) | (16,198) |
| Tax Provision | 10.00 | 36.00 | 14.00 | 10.00 | 7.00 | 1.00 | 24.00 | 26.00 |
| Net Income (Loss) | (8,303) | (7,933) | (8,503) | (6,857) | (3,102) | (20,125) | (44,246) | (16,224) |
| Earnings Per Share (Basic) | (0.76) | (1.46) | (1.59) | (1.99) | (1.15) | (15.83) | (30.92) | (14.41) |
| Earnings Per Share (Diluted) | (0.76) | (1.46) | (1.59) | (1.99) | (1.15) | (15.83) | (30.92) | (14.41) |
| Weighted Average Shares Outstanding (Basic) | 10,979 | 5,445 | 5,338 | 3,441 | 2,694 | 1,271 | 1,431 | 1,126 |
| Weighted Average Shares Outstanding (Diluted) | 10,979 | 5,445 | 5,338 | 3,441 | 2,694 | 1,271 | 1,431 | 1,126 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About BNGO
Bionano Genomics, Inc. (NASDAQ: BNGO) is a stock listed on the Nasdaq Stock Market under the ticker symbol BNGO. It last traded at $0.8800 (Nov 20, 2026, 9:30 AM ET), down 0.6% on the day. That gives Bionano Genomics a market capitalisation of $13.7M.
Over the past 52 weeks BNGO has traded between $0.8700 and $2.23.
Revenue for the quarter ended Mar 31, 2026 was $6.7M; a net loss of $8.3M. Revenue was up 3.6% from $6.5M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $6.7M | -$8.3M | -124.2% |
| Dec 31, 2025 | $8.0M | -$7.9M | -99.8% |
| Sep 30, 2025 | $7.4M | -$8.5M | -115.4% |
| Jun 30, 2025 | $6.7M | -$6.9M | -101.8% |
From Bionano Genomics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…